Compare SGMO & GRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGMO | GRX |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.2M | 150.6M |
| IPO Year | 2000 | 2007 |
| Metric | SGMO | GRX |
|---|---|---|
| Price | $0.41 | $9.58 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.75 | N/A |
| AVG Volume (30 Days) | ★ 3.7M | 38.1K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,567,000.00 | N/A |
| Revenue This Year | $4.79 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 88.60 | N/A |
| 52 Week Low | $0.35 | $8.93 |
| 52 Week High | $1.04 | $10.15 |
| Indicator | SGMO | GRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.42 | 36.79 |
| Support Level | $0.36 | $9.51 |
| Resistance Level | $0.56 | $9.69 |
| Average True Range (ATR) | 0.04 | 0.09 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 26.77 | 7.14 |
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.